from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3756c/proZ

LFCtreatmentdescriptionclass of inhibitor

-0.657

Amikacinug/mL Amikacintranslation

0.003

Cap5-10ug/mL Capreomycintranslation

-0.792

Rox10-50 ug/mL Roxithromycintranslation

-1.007

SM2-5 ug/mL Streptomycintranslation

-1.188

Tet5-10 ug/mL Tetracyclinetranslation

0.560

Rif0.2-5ug/mL Rifampicintranscription

-0.221

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.491

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.143

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.539

CPZ10-50 ug/mL Chlorpromazinerespiration

0.205

Clofazimine10-13 ug/mL Clofaziminerespiration

0.151

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.606

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.528

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.361

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.132

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.040

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.684

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.633

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.078

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.206

KCN5-20 ug/mL Potassium cyaniderespiration

-0.019

NaN30.2-2 mM Sodium aziderespiration

-0.881

Nigericin50 uM Nigericinrespiration

0.300

TRC10-150 ug/mL Triclosanrespiration

-0.327

TRZ10-25 ug/mL Thioridazinerespiration

-1.642

Valinomycin0.5-10 uM Valinomycinrespiration

-1.760

ZnSO42 mM ZnSO4respiration

-0.276

menadione6-10 ug/mL Menadionerespiration

-0.512

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.764

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.311

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.599

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.245

NRP_1Non-replicating persistence stage 1dosRassociated

-0.465

Amp0.2mg/mL AmpicillincellWall

-0.199

Cephalexin20-100 ug/mL CephalexincellWall

-0.826

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.289

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.478

EMB10-20 ug/mL EthambutolcellWall

-0.819

Eta12-40 ug/mL EthionamidecellWall

-0.879

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.271

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.979

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.651

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.364

BZA0.12 mg/mL BenzamidearomaticAmides

0.294

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.115

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.699

H2O24 mM hydrogen peroxideDNAdamaging

0.035

Levo10 ug/mL LevofloxacinDNAdamaging

0.182

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.105

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.536

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.120

UVUV-irradiationDNAdamaging

0.118

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.407

Antimycin12.5-50 ug/mL Antimycin A?

-0.007

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.717

PA_110-50 ug/mL Antitubercular compound PA-1?

0.470

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.238

PA8240.2-2 ug/mL PA-824?

0.893

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.589

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.474

Verapamil50 uM Verapamil?

0.408

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.797

methoxatin10-20 ug/mL Methoxatin?